(QSPT) Exchange-Traded Fund VIII - Overview
Etf: FLEX Options, QQQ Proxy, Buffer Strategy
| Risk 5d forecast | |
|---|---|
| Volatility | 15.5% |
| Relative Tail Risk | 2.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | -0.95 |
| Character TTM | |
|---|---|
| Beta | 0.764 |
| Beta Downside | 0.767 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.38% |
| CAGR/Max DD | 1.32 |
Description: QSPT Exchange-Traded Fund VIII December 28, 2025
FT Cboe Vest Nasdaq-100 Buffer ETF – September (BATS: QSPT) is a “Defined Outcome” ETF that, under normal market conditions, allocates essentially all of its capital to FLEX Options tied to the Invesco QQQ Trust (NASDAQ-100). These customized exchange-traded options let the manager set specific strike prices, option styles, and expiration dates to deliver a predefined downside buffer while capping upside participation.
Key characteristics (as of the latest filing) include an expense ratio of roughly 0.70% and an estimated $200 million in assets under management, making the fund non-diversified and heavily weighted toward technology, consumer discretionary, and health-care sectors that dominate the NASDAQ-100.
Performance drivers to watch are (1) US macro-policy, especially Federal Reserve interest-rate moves that affect tech valuation; (2) earnings trends in the top-10 NASDAQ-100 constituents (e.g., Apple, Microsoft, Amazon); and (3) volatility levels, since the buffer’s effectiveness hinges on option pricing dynamics.
Given the fund’s reliance on option-based outcomes, investors should monitor implied volatility indices (e.g., VIX) and the fund’s buffer-level utilization rate, which is typically disclosed quarterly.
For a deeper dive into the fund’s risk-return profile, you might explore ValueRay’s analytical tools.
What is the price of QSPT shares?
Over the past week, the price has changed by -0.87%, over one month by -0.96%, over three months by +1.41% and over the past year by +11.71%.
Is QSPT a buy, sell or hold?
What are the forecasts/targets for the QSPT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 36.4 | 15% |
QSPT Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 514.2m USD (514.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 514.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 514.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.73% (E(514.2m)/V(514.2m) * Re(8.73%) + (debt-free company))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)